Member Biography

We have two broad areas of research interest. The first area focuses on understanding the mechanism of tumor-selective, radiosensitization of NSCLC or PDA using a novel NQO1 bioactivatable drug. Our second area of interest is in investigating the effects of the immune system (STING and checkpoint inhibitors) on the efficacy of NQO1 bioactivatable drugs.

Post-doctoral Fellowship - UT Southwestern Medical Center, Dallas, TX 12/2016

PHMD - Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 12/2010